<； p >； The present Invention relates to Peptides, Proteins, Nucleic acids and Cells for use in immunotherapeutic methods.In particular, the present Invention relates to Immunotherapy against cancer.The present Invention also relates to epitope Peptide for tumor Associated T cells alone or in combination with other tumor Associated Peptides, e.g.Can be used as pharmaceutical Active principles in vaccine compositions intended to stimulate antitumor immune responses.To stimulate or ex vivo T lymphocytes, which are then transferred to the patients.The peptides bound to Molecules of the major histocompatibility complex (MHC), or peptides as such, may also be targets of Antibodies, T Lymphocyte receptor solubleAnd other Molecules of Union. <； / p >；La presente solicitud menciona diferentes peptidos cortos que se unen a MHC para ser usados en inmunoterapias contra el cancer； Se mencionan ademas los usos, metodos, linfocitos T, y anticuerpos que reconocen los peptidos.
